In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 5th, 2005 | 23 | No |
Popular Name: Myricetin Myricetin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 529-44-2 , [529-44-2]
3,3',4',5,5',7-hexahydroxyflavone
3,3',4',5,5',7-Hexahydroxyflavone; Cannabiscetin; Myricetol
3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one
3,3?,4?,5,5?,7-Hexahydroxyflavone
3,5,7,3',4',5'-Hexahydroxyflavone
3,5,7,3',4',5'-Hexahydroxyflavone; 529-44-2; C10107; Myricetin
3,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chromen-4-one
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one
529-44-2; Myricetin; Prestwick_342
Cannabiscetin, Myricetol, Myricitin
Myricetin with HPLC [529-44-2]; (3,5,7,3',4',5'-Hexahydroxyflavone, Cannabiscetin)
Myricetin [529-44-2]; (3,5,7,3',4',5'-Hexahydroxyflavone, Cannabiscetin)
Myricetin [529-44-2]; (Cannabiscetin; 3,5,7,3',4',5'-Hexahydroxyflavone)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.39 | -5.05 | -14 | 6 | 8 | 0 | 152 | 318.237 | 1 | ↓ |
Mid Mid (pH 6-8) | 1.65 | -4.78 | -43.31 | 5 | 8 | -1 | 154 | 317.229 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_source | Isol. from the bark of Myrica rubra and Myrica nagi; widespread in the plant world, occurring in seeds, flowers and stems, often as glycosides | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 3.01e-01 g/l | DrugBank-experimental |
M.P. | 351 C | Indofine |
MP | 351o C | Indofine |
MP | 360 | TCI |
Purity | 95% | Fluorochem |
Mp [°C] | >300 | Acros Organics |
M.P. | >350 C (dec) | Indofine |
MP | >350o C (d) | Indofine |
biological_use | Antibacterial | IBScreen Bioactives |
Therapy | antiHIV, topoisomerase II inhibitor | SMDC MicroSource |
biological_use | Antioxidant | IBScreen Bioactives |
biological_use | Antiviral activity | IBScreen Bioactives |
UniProt Database Links | AOXA_RAT; F3ST_FLACH; FAOMT_VITVI; FOMT2_WHEAT; MOMT_CATRO; OMT15_ORYSJ; OMT17_ORYSJ; OMT1_ARATH | ChEBI |
biological_use | Bioflavonoid | IBScreen Bioactives IBScreen Bioactives |
Patent Database Links | EP1808169; EP1847265; EP1915986; EP1925311; EP1932517; US2006135585; US2007202195; WO2007103555; WO2007109802; WO2007120897; WO2007131767 | ChEBI |
Target | Eukaryotic translation initiation factor 4E(P06730)&Heparin-binding growth factor 2(P09038) | Herbal Ingredients Targets |
APPEARANCE | Greenish powder | Indofine |
mechanism | Novel natural inhibitor of neoplastic cell transformation and MEK1 | IBScreen Bioactives |
Target | NULL | Selleck Chemicals |
S phrase | S24/25: Avoid contact with skin and eyes. | Acros Organics |
biological_use | Shows anti-HIV activity | IBScreen Bioactives |
SOLUBILITY | Soluble in Alcohols; Hygroscopic | Indofine |
Target | Vascular endothelial growth factor A(P15692)&Hypoxia-inducible factor 1-alpha(Q16665)&Estrogen receptor(P03372)&Canalicular multispecific organic anion transporter 1(Q92887)&Nuclear receptor subfamily 1 group I member 2(O75469)&Cytosolic phospholipase A2( | Herbal Ingredients Targets |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP19A-1-E | Cytochrome P450 19A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10000 | 0.30 | Binding ≤ 10μM |
INSR-1-E | Insulin Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2600 | 0.34 | Binding ≤ 10μM |
KD4DL-1-E | Lysine-specific Demethylase 4D-like (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.34 | Binding ≤ 10μM |
LGUL-2-E | Glyoxalase I (cluster #2 Of 2), Eukaryotic | Eukaryotes | 560 | 0.38 | Binding ≤ 10μM |
MRP1-1-E | Multidrug Resistance-associated Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.34 | Binding ≤ 10μM |
MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.35 | Binding ≤ 10μM |
Q965D5-1-E | Enoyl-acyl-carrier Protein Reductase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.39 | Binding ≤ 10μM |
Q965D7-2-E | Fatty Acid Synthase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.35 | Binding ≤ 10μM |
XDH-2-E | Xanthine Dehydrogenase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2380 | 0.34 | Binding ≤ 10μM |
CP1A1-1-E | Cytochrome P450 1A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 370 | 0.39 | ADME/T ≤ 10μM |
CP1B1-1-E | Cytochrome P450 1B1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 27 | 0.46 | ADME/T ≤ 10μM |
Z50425-11-O | Plasmodium Falciparum (cluster #11 Of 22), Other | Other | 6310 | 0.32 | Functional ≤ 10μM |
FPS-1-V | Tyrosine-protein Kinase Transforming Protein FPS (cluster #1 Of 1), Viral | Viruses | 1800 | 0.35 | Binding ≤ 10μM |
Q7ZJM1-1-V | Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral | Viruses | 7600 | 0.31 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q965D5_PLAFA | Q965D5 | Enoyl-acyl-carrier Protein Reductase, Plafa | 400 | 0.39 | Binding ≤ 1μM |
LGUL_HUMAN | Q04760 | Glyoxalase I, Human | 560 | 0.38 | Binding ≤ 1μM |
Q7ZJM1_9HIV1 | Q7ZJM1 | Human Immunodeficiency Virus Type 1 Integrase, 9hiv1 | 600 | 0.38 | Binding ≤ 1μM |
CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 10000 | 0.30 | Binding ≤ 10μM |
Q965D5_PLAFA | Q965D5 | Enoyl-acyl-carrier Protein Reductase, Plafa | 400 | 0.39 | Binding ≤ 10μM |
Q965D7_PLAFA | Q965D7 | Fatty Acid Synthase, Plafa | 2000 | 0.35 | Binding ≤ 10μM |
LGUL_HUMAN | Q04760 | Glyoxalase I, Human | 560 | 0.38 | Binding ≤ 10μM |
Q7ZJM1_9HIV1 | Q7ZJM1 | Human Immunodeficiency Virus Type 1 Integrase, 9hiv1 | 2000 | 0.35 | Binding ≤ 10μM |
INSR_HUMAN | P06213 | Insulin Receptor, Human | 2600 | 0.34 | Binding ≤ 10μM |
KD4DL_HUMAN | B2RXH2 | Lysine-specific Demethylase 4D-like, Human | 3000 | 0.34 | Binding ≤ 10μM |
MRP1_HUMAN | P33527 | Multidrug Resistance-associated Protein 1, Human | 2400 | 0.34 | Binding ≤ 10μM |
MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 1700 | 0.35 | Binding ≤ 10μM |
FPS_FUJSV | P00530 | Tyrosine-protein Kinase Transforming Protein FPS, Fujsv | 1800 | 0.35 | Binding ≤ 10μM |
XDH_HUMAN | P47989 | Xanthine Dehydrogenase, Human | 2380 | 0.34 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 6309.57344 | 0.32 | Functional ≤ 10μM |
CP1A1_HUMAN | P04798 | Cytochrome P450 1A1, Human | 370 | 0.39 | ADME/T ≤ 10μM |
CP1B1_HUMAN | Q16678 | Cytochrome P450 1B1, Human | 27 | 0.46 | ADME/T ≤ 10μM |
Description | Species |
---|---|
ABC-family proteins mediated transport | |
Cobalamin (Cbl, vitamin B12) transport and metabolism | |
Endogenous sterols | |
Estrogen biosynthesis | |
Insulin receptor recycling | |
IRS activation | |
PPARA activates gene expression | |
Purine catabolism | |
SHC activation | |
Signal attenuation | |
Signaling by Insulin receptor | |
Smooth Muscle Contraction | |
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | |
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | |
Xenobiotics |